Universal (0LJD) AI Stock Analysis

Universal

(LSE:0LJD)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Global sourcing and customer positioningUniversal’s multi-origin sourcing capabilities, regional expertise, and close customer relationships support its ability to meet required tobacco quality and volumes. This positioning can protect customer relevance and market share through changing crop conditions and industry oversupply.

Negative Factors

Severe profitability deteriorationThe sharp decline in revenue and operating income shows that Universal’s current earnings base is vulnerable to adverse product mix, purchasing delays, and operating pressure. Persistently weak profitability would constrain reinvestment, debt reduction, and dividend support.

Universal (0LJD) vs. iShares MSCI United Kingdom ETF (EWC)

Market Cap: $1.03B
Dividend Yield: 7.93%
Average Volume (3M): 265
Price to Earnings (P/E): 54.5
Beta (1Y): 0.45
Revenue Growth: -3.04%
EPS Growth: -81.53%
Country: UK
Employees: 11,250
Sector: Consumer Defensive
Sector Strength: 62
Industry: Tobacco

Universal Business Overview & Revenue Model

Company Description

Universal Corporation is a global agricultural enterprise specializing in the processing and supply of leaf tobacco and a diverse range of plant-based ingredients. Its activities are organized into two primary segments: Tobacco Operations and Ingredi...

Universal Earnings Call Summary

Earnings Call Date:Aug 04, 2026(Q1-2027)|% Change Since:-19.15%|Next Earnings Date:Nov 03, 2026

Earnings Call SentimentNeutral

The call was mixed. Current financial performance was materially weaker, with double-digit declines in consolidated and tobacco revenue, sharply lower operating income, a consolidated net loss, tobacco-market oversupply, and ongoing ingredients headwinds. However, management maintained its full-year tobacco sales plan, reported strong liquidity, described disciplined sourcing and inventory initiatives, expected normalized tobacco margins, and reiterated long-term investment and improvement plans for both tobacco and ingredients. The positive strategic outlook and liquidity position were balanced by significant current-period declines and execution challenges.

Positive Updates

Full-Year Tobacco Sales Plan Maintained

Management said customer demand expectations and customer indications remain consistent with the fiscal year sales plan, with shipments expected to be weighted more heavily toward the second half of fiscal year 2027.

Negative Updates

Tobacco Revenue and Operating Income Decline

Tobacco operations revenue was $437 million in the first quarter of fiscal year 2027, down 13% year over year. Segment operating income was $3.5 million versus $35.7 million in the prior-year quarter. Management cited more pronounced seasonality, delayed customer purchasing decisions following the shift to oversupply, lower tobacco carryover crop sales, less favorable product mix, and a $4.4 million negative operating-income variance from foreign-currency movements.

Company Guidance

Management said customer demand expectations remain consistent with the fiscal year sales plan, with shipments expected to be weighted more heavily in the second half of the fiscal year, and it would not expect to see the large inventory write downs that it had last year. Tobacco margins are expected to be “pretty normalized” from a percentage basis on where they were before, uncommitted inventories are expected to return to the 20% target as the season progresses, and working capital should be reduced from recent years due to lower green tobacco prices, although quarter-end levels will fluctuate with shipping timing, customer orders, and carryover crops. CapEx is estimated to be above maintenance levels this year, SG&A is expected to be in the 300 to $310 million band, and interest expense is expected to be down a little from last year. Ingredients improvement efforts are expected to take time and continue through the next fiscal year, with the company focused on steady and incremental advances; potential additional tobacco volumes this year could occur to hedge against risks that could occur next season.

Universal Risk Analysis

Universal disclosed 24 risk factors in its most recent earnings report. Universal reported the most risks in the "Production" category.

Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

Universal Peers Comparison

Overall Rating

UnderperformOutperform

Sector (62)

Financial Indicators

GB:0LJD against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BTI	68Neutral	$132.23B	15.73	13.38%	5.40%	4.47%	117.22%
PM	68Neutral	$325.43B	30.48	-119.68%	2.88%	7.91%	24.06%
MO	65Neutral	$129.80B	16.12	-279.72%	5.50%	2.41%	-7.63%
TPB	65Neutral	$1.35B	28.28	11.93%	0.47%	20.10%	-3.19%
Sector *	62Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
XXII	40Underperform	$1.34M	0.00	-20.47%	―	-27.44%	99.95%

* Consumer Defensive Sector Average

Performance Comparison

GB:0LJD and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GB:0LJD	Universal Corporation	41.55	-5.97	-12.56%
MO	Altria	78.03	24.95	47.00%
BTI	British American Tobacco	61.52	12.03	24.30%
PM	Philip Morris International	208.79	69.13	49.50%
XXII	22nd Century Group	0.07	-464.93	-99.99%
TPB	Turning Point Brands Inc	67.31	-25.97	-27.84%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Universal AI Stock Analysis